Drug ID: | NPD1155 |
Drug Name: | HF-0699 |
Molecular Formula: | C13H31N7O |
Canonical SMILES: | NCCCCNCCCN=C([C@H](CCCNC(=N)N)N)O |
Standard InCHI: | InChI=1S/C13H31N7O/c14-6-1-2-7-18-8-4-10-19-12(21)11(15)5-3-9-20-13(16)17/h11,18H,1-10,14-15H2,(H,19,21)(H4,16,17,20)/t11-/m0/s1 |
Standard InCHIKey: | CXJFWYHJODPOFD-NSHDSACASA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB002270 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 301.26 |
ALogP | -4.2346 |
MLogP | 2.01 |
XLogP | -0.638 |
HDA | 8 |
HBD | 7 |
Rotatable Bonds | 18 |
TPSA | 158.56 |
RO5 Violation | 2 |